In a few reports, drug inhibition of GSK3β has been shown to improve maturation and antitumor activity of NK cells with elevated GSK3β, such as IL-15 expanded NK cells or NK cells isolated from AML patients [5,6,7]. Here, GSK3B is linked to acute myeloid leukemia.